Clinical Outcomes and Costs Analyses in Use of Goal Directed Therapy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01995786

Enrollment

200

Registered

2013-11-27

Start date

2012-01-31

Completion date

Unknown

Last updated

2016-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Complications

Keywords

Fluid Therapy, Cost-Benefit Analysis, Hemodynamics, Cost Control

Brief summary

The aim of the study is to evaluate clinical and economic impact of Goal Directed Fluid Therapy according to NICE haemodynamic protocol. Haemodynamic parameters were assessed using automated pulse contour analysis (Flotrac/Vigileo®). A specific dedicated software has been developed to perform clinical and expenditures data collection, both retrospective and prospective data are archived.

Interventions

DEVICEGoal Directed Fluid Therapy FloTrac/Vigileo

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

HEALTH_SERVICES_RESEARCH

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients selected for major abdominal surgery

Exclusion criteria

•Patients under the age of 18, patients with hemodynamically significant aortic regurgitation and heart rhythm disorders

Design outcomes

Primary

Measure	Time frame
rate of reduction of postoperative spending	30 day postoperative

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026